Galecto Inc (GLTO)
5.62
-0.22
(-3.85%)
USD |
NASDAQ |
Nov 22, 16:00
5.60
-0.02
(-0.36%)
After-Hours: 20:00
Galecto Net Income (Quarterly): -3.883M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.883M |
| June 30, 2024 | -5.338M |
| March 31, 2024 | -5.477M |
| December 31, 2023 | -6.475M |
| September 30, 2023 | -8.136M |
| June 30, 2023 | -10.74M |
| March 31, 2023 | -12.99M |
| December 31, 2022 | -14.07M |
| September 30, 2022 | -13.73M |
| June 30, 2022 | -16.89M |
| March 31, 2022 | -16.94M |
| Date | Value |
|---|---|
| December 31, 2021 | -13.41M |
| September 30, 2021 | -12.70M |
| June 30, 2021 | -12.30M |
| March 31, 2021 | -13.34M |
| December 31, 2020 | -11.58M |
| September 30, 2020 | -11.65M |
| June 30, 2020 | -5.935M |
| March 31, 2020 | -5.674M |
| December 31, 2019 | -24.42M |
| September 30, 2019 | -4.105M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-24.42M
Minimum
Dec 2019
-3.883M
Maximum
Sep 2024
-11.28M
Average
-11.98M
Median
Net Income (Quarterly) Benchmarks
| Novo Nordisk AS | 4.023B |
| Genmab AS | 186.57M |
| Ascendis Pharma AS | -109.10M |
| Evaxion Biotech AS | -1.935M |
| IO Biotech Inc | -24.02M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.84M |
| EPS Diluted (Quarterly) | -3.39 |
| Enterprise Value | -12.28M |
| Earnings Yield | -341.6% |